Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

light-activated

A new light-activated drug for treating Parkinson’s has been developed by a research team led by the University of Barcelona, Spain.

The drug – named MRS7145 – is placed within a brain implant and then activated by shining a light on it.

The effect of the newly developed drug was tested on live mice to see if it could improve their motor function. The results – published in ‘Journal of Controlled Release’ – showed that MRS7145 reduced tremors and seizures and improved the mice’s ability to walk.

Professor Francisco Ciruela, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, Spain, said he envisaged the drug being administered by smart phones, with “the doctor (controlling) in a precise manner the release of the most efficient dose of the active drug in the place of action”.

For more information on Parkinson’s research please visit the EPDA website.

Go Back

Share this story

Comments


Related articles


Research

Advances

“Some serious Parkinson’s research breakthroughs are on the horizon”

Dr Simon Stott tells us why it’s an exciting time for Parkinson’s resea

READ MORE
Research scientist Andy Howden smiles for a photo in a lab coat.

Interviews

A day in the life of a Parkinson’s disease researcher

What is it like being a scientist?

READ MORE
brain-stem-cell-surgery

Advances

Researchers carry out ‘world-first’ stem cell treatment for Parkinson’s disease

Revolutionary stem cells injected into brain of Parkinson’s patient

READ MORE